Evidence map›Paper›PMID 24596084›Full record

Trial reportNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2014

A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.

Tetsuya Kawamura, Mitsuhiro Yoshimura, Yoichi Miyazaki, Hidekazu Okamoto, Kenjiro Kimura, Keita Hirano, Masato Matsushima, Yasunori Utsunomiya, Makoto Ogura, Takashi Yokoo and 22 more

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 4 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 4 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Immunosuppressive agents for treating IgA nephropathy.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. IgA nephropathy management: what does the future hold?Kidney international supplements · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 15 institutions in 1 country.

Tetsuya KawamuraDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Mitsuhiro YoshimuraDepartment of Internal Medicine, Kanazawa Medical Centre, Kanazawa, Japan.
Yoichi MiyazakiDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Hidekazu OkamotoDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Kenjiro KimuraDivision of Kidney and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Keita HiranoDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Masato MatsushimaDivision of Clinical Epidemiology, Research Center for Medical Science, Jikei University School of Medicine, Tokyo, Japan.
Yasunori UtsunomiyaDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Makoto OguraDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Takashi YokooDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Hideo OkonogiDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Takeo IshiiDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Akihiko HamaguchiDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Hiroyuki UedaDivision of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Akira FurusuSecond Department of Internal Medicine, Nagasaki University Hospital of Medicine and Dentistry, Nagasaki, Japan.
Satoshi HorikoshiDivision of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Yusuke SuzukiDivision of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Takanori ShibataDivision of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Takashi YasudaDivision of Kidney and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Sayuri ShiraiDivision of Kidney and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Toshiyuki ImasawaDepartment of Internal Medicine, Chiba-East Hospital, Chiba, Japan.
Koichi KanozawaDivision of Kidney and Hypertension, Department of Internal Medicine, Saitama University Medical Centre, Saitama, Japan.
Akira WadaDepartment of Internal Medicine, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
Izumi YamajiDepartment of Internal Medicine, Teine Keijinkai Hospital, Sapporo, Japan.
Naoto MiuraDivision of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Hirokazu ImaiDivision of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Kenji KasaiDepartment of Internal Medicine, Fuji City Central Hospital, Fuji, Japan.
Jun SomaDepartment of Internal Medicine, Iwate Prefectural Central Hospital, Morioka, Japan.
Shouichi FujimotoDepartment of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Seiichi MatsuoDivision of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Nagoya, Nagoya, Japan.
Yasuhiko TominoDivision of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Special IgA Nephropathy Study Group
Jikei University School of Medicine · JPJuntendo University · JPSt. Marianna University School of Medicine · JPAichi Medical University · JPChiba East Hospital · JPFujisawa City Hospital · JPIwate Prefectural Central Hospital · JPKanazawa Medical Center · JPNagasaki University Hospital · JPNagoya University · JPOsaka National Hospital · JPSaitama University · JPShowa University · JPTeine Keijinkai Hospital · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aim was, for the first time, to conduct a multicenter randomized controlled trial to evaluate the effect of tonsillectomy in patients with IgA nephropathy (IgAN).

methodsPatients with biopsy-proven IgAN, proteinuria and low serum creatinine were randomly allocated to receive tonsillectomy combined with steroid pulses (Group A; n = 33) or steroid pulses alone (Group B; n = 39). The primary end points were urinary protein excretion and the disappearance of proteinuria and/or hematuria.

resultsDuring 12 months from baseline, the percentage decrease in urinary protein excretion was significantly larger in Group A than that in Group B (P < 0.05). However, the frequency of the disappearance of proteinuria, hematuria, or both (clinical remission) at 12 months was not statistically different between the groups. Logistic regression analyses revealed the assigned treatment was a significant, independent factor contributing to the disappearance of proteinuria (odds ratio 2.98, 95% CI 1.01-8.83, P = 0.049), but did not identify an independent factor in achieving the disappearance of hematuria or clinical remission.

conclusionsThe results indicate tonsillectomy combined with steroid pulse therapy has no beneficial effect over steroid pulses alone to attenuate hematuria and to increase the incidence of clinical remission. Although the antiproteinuric effect was significantly greater in combined therapy, the difference was marginal, and its impact on the renal functional outcome remains to be clarified.

Indexed as

TonsillectomyAdultBiopsyFemaleFollow-Up StudiesGlomerular Filtration RateGlomerulonephritis, IGAGlucocorticoidsHumansKidneyMaleMethylprednisolonePulse Therapy, DrugRemission InductionTime FactorsTreatment OutcomeGlucocorticoidsMethylprednisoloneclinical remissionestimated glomerular filtration ratehematuriaproteinuria

Identifiers

PMID24596084
PMCPMC4106640
OpenAlexW2143225245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.